RIYADH HIV CLINICAL FORUM

RIYADH, SAUDI ARABIA   NOVEMBER 2020

THE GULF HIV CLINICAL FORUM 2019: INTEGRASE INHIBITORS IS COMING TO RIYADH ON 2 DECEMBER!

 

The meeting will include plenary lectures and plenty of opportunity to interact with key experts in the field during Q&A and discussions!

 

This state-of-the-art program provides challenging plenary lectures followed by ample time for Q&A and debate, stimulating interaction and the sharing of knowledge within the HIV treating community in Saudi Arabia. Additionally, the program includes clinical case presentations to discuss real-life discussions.

The MoH Annual HIV/AIDS Conference 2019 and Gulf HIV Clinical Forum 2019 are accredited for 15 CME/CPD hours by the Saudi Commission for Health Specialties.

GULFHCF2019_CME-08.png
 
BACKGROUND

 

The HIV CLINICAL FORUM is developed as part of a series of interactive programs that provide independent medical education on emerging topics in HIV. The program features regional experts in order to provide HIV clinicians and allied healthcare professionals with updates on the latest developments related to HIV management, providing opportunities for sharing of clinical experience and presenting results from ongoing and completed cohorts / research programs.

 

Furthermore, the HIV CLINICAL FORUM encourages skills building for optimal interpretation of research results, developing  collaborations and initiating research projects.

 
LOCAL CHAIR
PROGRAM CHAIR

Charles Boucher, MD, PhD

Erasmus Medical Center,

the Netherlands

Alamri, Bandar.png

Bandar Alamri, MD

East Jeddah Hospital,

Kingdom of Saudi Arabia

Register for the

Gulf HIV Clinical Forum

Riyadh | 2 December 2019

PRELIMINARY PROGRAM
 

MONDAY, 2 DECEMBER 2019

09:00h     Welcome, Introduction and Goals

                Bandar Alamri, MD - East Jeddah Hospital, Jeddah, Kingdom of Saudi Arabia

                Charles Boucher, MD, PhD - Erasmus Medical Center, Rotterdam, the Netherlands

Session 1 - Integrase Inhibitors as part of clinical management of PLWH

Chairs: Bandar Alamri & Charles Boucher

09.05h     Attributes of INSTIs as a first line treatment option

                Sanjay Bhagani, BSc, FRCP - Royal Free Hospital, London, UK

09.30h     Two versus three drugs - what are the data?

                Roger Paredes, MD, PhD - Hospital Germans Trias i Pujol, Badalona, Spain

09.55h     Integrase inhibitor resistance: does it matter?

                Charles Boucher, MD, PhD - Erasmus Medical Center, Rotterdam, the Netherlands

10.20h     Optimal use of INSTIs in KSA

                Ghassan Wali, MD, FRCP(C) - King Faisal Specialist Hospital and Research Centre, Jeddah, Kingdom of Saudi Arabia

10.45h     Discussion

11:00h     Coffee Break

Session 2 - Factors affecting the choice of antiretroviral therapy

Chairs: Sanjay Bhagani & Ghassan Wali

11.30h     Switching ARV therapy - clinical and resistance considerations

                Roger Paredes, MD, PhDHospital Germans Trias i Pujol, Badalona, Spain

11.55h     Switching ARV therapy - clinical and pharmacological considerations

                Andrea Calcagno, MD, DTM&H - University of Torino, Torino, Italy

12.20h     ARV toxicity and their management (including weight gain)

                Laura Waters, MD - Central & North West London NHS Trust, London, UK

12.45h     Discussion

13:00h     Lunch

Session 3 - Optimal ARV treatment in special populations

Chairs: Roger Paredes & Abdulla Baradwan

14.00h     Antiretroviral therapy in pregnancy: Risks and benefits

                Sanjay Bhagani, BSc, FRCPRoyal Free Hospital, London, UK

14.25h     Antiretroviral therapy in HIV-TB co-infected patients

                Mohammad Alhazmi, MD, FACP - King Fahad Central Hospital Jizan, Jizan, Kingdom of Saudi Arabia

14.50h     Breast feeding in HIV

                Batool Ali, MD - East Jeddah Hospital, Jeddah, Kingdom of Saudi Arabia

15.10h     Clinical case

                Laura Waters, MD - Central & North West London NHS Trust, London, UK

15.30h     Discussion

15:45h     Coffee Break

Session 4 - ARV treatment options in the near future

Chairs: Bandar Alamri & Charles Boucher

16.15h     Novel treatment options - Long Acting Antiretroviral compounds

                Andrea Calcagno, MD, DTM&HUniversity of Torino, Torino, Italy

16.40h     Reducing HIV stigma and promoting early diagnosis

                Bandar Alamri, MD - East Jeddah Hospital, Jeddah, Kingdom of Saudi Arabia

17:00h     Closing remarks

                Bandar Alamri, MD - East Jeddah Hospital, Jeddah, Kingdom of Saudi Arabia

SPONSOR

 

WORKING ON BEHALF OF VIIV HEALTHCARE IN HIV

The Gulf HIV Clinical Forum 2019 is supported by an independent educational grant from GSK/ViiV Healthcare.

GSK/ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.

MEETING PARTNER

EDUCATIONAL PARTNER

MEETING ORGANIZER

 

Access the meeting proceedings of the 

HAVE A LOOK AT THE PREVIOUS MEETING'S PRESENTATIONS AND CONTENT HERE:

 
PRACTICAL INFORMATION

Practical Information

We trust that the following information (in alphabetical order) will assist you in organizing your registration and stay in Riyadh.

 

Badges

Make sure to pick up your badge at the registration desk. All participants are requested to wear the badge at all times during the conference to ensure admission to the meeting and venue.

 

Certificate of Attendance

A certificate of attendance will be sent by e-mail after the workshop.

 

Conference materials

Conference materials can be obtained upon registration at the registration desk of the conference venue starting from 8:00 AM on Monday, 2 December.

 

Conference language

The official conference language is English.

 

Disclaimer

This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop.

Liability and insurance

By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.

Meeting venue

The meeting will be held at the following venue:

 

VOCO Hotel Riyadh

King Fahad Branch Rd
Riyadh 12731
Kingdom of Saudi Arabia

T: +966 11 45 79 999

W: www.ihg.com/voco/hotels/gb/en/riyadh/ruhsd/hoteldetail

E: vocoriyadh.reservation@ihg.com

Internet access

Free Wi-Fi will be available in the meeting room. 

Payment and procedure of online registration

Registration is free of charge for all healthcare practitioners. Your registration will be confirmed as soon as possible. If you do not receive a confirmation within three days after your registration, please contact the organizing secretariat email: info@virology-education.com.

 

Photographs, audio and video recording

Photographs as well as audio and video recordings are not permitted at the official meeting sessions. Only the official medical writer, appointed by the organization, may make recordings. All presentations, will be posted on the workshop website (under Workshop Materials) as soon as possible after the workshop is finished, provided the speaker has given permission to do so.

Contact

Inquiries

For any inquiries or questions, please contact Virology Education at info@virology-education.com or call +31 (0)30 230 7147. You can also contact us by filling out the contact form.

Jesper Niesen

Project Manager

jesper@vironet.com

Contact form

 

Conference materials:

infectiousdiseasesonline.com

© 2020 By Virology Education